Comments
Loading...
Corcept Therapeutics (NASDAQ:CORT) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Corcept Therapeutics (CORT)?
The most recent guidance for Corcept Therapeutics (CORT) was reported on February 8, 2021 for the full year 2020. The company provided earnings per share guidance in the range of $0.85 to $0.85, compared to the estimated EPS of $0.80. Additionally, Corcept Therapeutics forecasted revenue between $0.35B and $0.35B for the quarter.
Browse guidance and forecast on all stocks.